Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at AED 33.5B, ahead of BioNTech (AED 31.3B) and Gilead Sciences (AED 27.8B). Figures as of 18 Nov 2026, 20:24 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenAED 33.5B
Median
AED 1.6B
Combined market value
AED 3.08T
Countries
5

Market values as of .

All countries
All sectors
Biotech
AED
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareAED 33.5BAED 883.7BAED 1,633.77 2.86% down 34% up United States
2BioNTechBNTX · Health CareAED 31.3BAED 76.1BAED 307.01 1.50% down 16% down Germany
3Gilead SciencesGILD · Health CareAED 27.8BAED 771.8BAED 622.25 0.49% down 33% up United States
4argenxARGX · Health CareAED 12.8BAED 218.2BAED 3,470.39 0.28% down 4% up Belgium
5BiogenBIIB · Health CareAED 11BAED 136BAED 920.00 0.12% down 49% up United States
6ModernaMRNA · Health CareAED 9.5BAED 293.8BAED 726.02 4.41% down 755% up United States
7ImmunovantIMVT · Health CareAED 3.3BAED 25.3BAED 122.23 0.21% up 43% up United States
8QiagenQGEN · Health CareAED 3.1BAED 37.6BAED 182.24 0.26% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareAED 2.6BAED 60.5BAED 597.23 1.99% down 20% up United States
10RepligenRGEN · Health CareAED 2.1BAED 40.4BAED 632.71 6.22% up 5% up United States
11Krystal BiotechKRYS · Health CareAED 1.8BAED 34.2BAED 1,155.22 5.35% up 46% up United States
12ExelixisEXEL · Health CareAED 1.8BAED 61.5BAED 251.97 0.15% up 63% up United States
13Revolution MedicinesRVMD · Health CareAED 1.4BAED 126.8BAED 586.40 1.86% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareAED 1.3BAED 38.1BAED 446.70 0.09% up 87% up United States
15CRISPR TherapeuticsCRSP · Health CareAED 1.3BAED 14.4BAED 148.53 0.72% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareAED 1.2BAED 21.3BAED 174.86 5.61% up 14% up United States
17Bio-TechneTECH · Health CareAED 972.2MAED 42BAED 267.36 0.23% up 26% up United States
18Kodiak SciencesKOD · Health CareAED 770.8MAED 23.5BAED 358.92 0.96% up 396% up United States
19Twist BioscienceTWST · Health CareAED 672.3MAED 29BAED 425.42 3.42% up 340% up United States
20VaxcytePCVX · Health CareAED 638.9MAED 34.1BAED 215.15 1.38% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareAED 491.5MAED 40.2BAED 352.63 0.04% up 37% up United States
22ImmunityBioIBRX · Health CareAED 324.4MAED 26.2BAED 24.63 7.11% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareAED 258.9MAED 16.9BAED 104.49 0.14% down 88% up United States
24CG OncologyCGON · Health CareAED 119.3MAED 26.3BAED 294.23 1.48% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (AED 33.5B), BioNTech (AED 31.3B) and Gilead Sciences (AED 27.8B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 20:24 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of AED 3.08T as of 18 Nov 2026, 20:24 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.